Vivani Medical (NASDAQ:VANI – Get Free Report) is one of 73 publicly-traded companies in the “Electromedical equipment” industry, but how does it compare to its competitors? We will compare Vivani Medical to related businesses based on the strength of its valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.
Insider and Institutional Ownership
8.4% of Vivani Medical shares are owned by institutional investors. Comparatively, 48.2% of shares of all “Electromedical equipment” companies are owned by institutional investors. 55.6% of Vivani Medical shares are owned by company insiders. Comparatively, 10.6% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Risk & Volatility
Vivani Medical has a beta of 2.64, indicating that its stock price is 164% more volatile than the S&P 500. Comparatively, Vivani Medical’s competitors have a beta of 12.57, indicating that their average stock price is 1,157% more volatile than the S&P 500.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Vivani Medical Competitors||160||682||1873||94||2.68|
Vivani Medical currently has a consensus target price of $7.00, indicating a potential upside of 652.69%. As a group, “Electromedical equipment” companies have a potential upside of 57.11%. Given Vivani Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than its competitors.
This table compares Vivani Medical and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Vivani Medical Competitors||-408.26%||-118.51%||-33.88%|
Earnings and Valuation
This table compares Vivani Medical and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Vivani Medical||N/A||-$13.89 million||-2.38|
|Vivani Medical Competitors||$1.00 billion||$85.24 million||1.45|
Vivani Medical’s competitors have higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Vivani Medical competitors beat Vivani Medical on 7 of the 13 factors compared.
About Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.